Gary Ingenito - Nov 27, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Stock symbol
CPRX
Transactions as of
Nov 27, 2024
Transactions value $
-$224,534
Form type
4
Date filed
11/29/2024, 08:09 PM
Previous filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $48.1K +12K +23.35% $4.01 63.4K Nov 27, 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$196K -8.63K -13.62% $22.74 54.8K Nov 27, 2024 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale -$76.4K -3.37K -6.15% $22.67 51.4K Nov 27, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -12K -1.14% $0.00 1.04M Nov 27, 2024 Common Stock 12K $4.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Options vested in three annual tranches beginning on January 2, 2019.